Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Thalassaemia

- PMLiVE

Sanofi exits R&D pact with Alnylam on rare disease

Exit also frees up $700m equity investment

- PMLiVE

Bluebird plays down report of EU gene therapy approval

Charity says Zynteglo (LentiGlobin) has already achieved a conditional marketing authorisation

Winners of the HSJ Partnership Awards 2019 unveiled

The winners of the HSJ Partnership Awards 2019 were announced on 20 March at a prestigious black-tie awards ceremony at Park Plaza, Westminster.

Wilmington Healthcare

- PMLiVE

NHS needs £900m a year to avoid crippling staff shortages

Report predicts nurse shortage will triple to over 100,000 within the next 10 years

- PMLiVE

Genomics integration: can the NHS rise to the challenge?

Experts gather to discuss the UK’s genomic landscape

- PMLiVE

NICE partially clears Darzalex combo in blood cancer

Approved in second-line use under  CDF

- PMLiVE

Trump’s Brexit trade plan is bad for NHS, say campaigners

People’s Vote claims US wants to end NHS’ current regime of controlling drug costs

- PMLiVE

New ‘NHSX’ unit will lead health service digital transformation

Will bring together public and private sector to accelerate change

Pharma iPad detailing doctors physicians

A genomics and digital-led NHS is possible – but investment in staff essential

Powerful technologies will lead to an “evolution of the patient-doctor relationship”

- PMLiVE

UK unveils new antibiotic buying plan, pharma incentives

Health minister compares upfront payment model to Spotify

- PMLiVE

NHS regional footprints

What to expect from 2019

- PMLiVE

Young are being failed by mental health service, says UK report

Just 30% with a mental health condition get NHS treatment

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links